MAXIS offers strategic and operational expertise to emerging medical device companies, helping them successfully commercialize their products and increase their value. They use data-driven processes to expedite product adoption and penetration in the market. MAXIS also manages projects ranging from short-term consultation to long-term clinical program management. Founded in 2003 and based in San Jose, California, MAXIS focuses on maximizing the preclinical, regulatory, clinical, and commercial success of new medical device technologies. In February 2023, MAXIS was acquired by Avania, although the terms of the transaction were not disclosed.